Dongbao Bio-Tech released its performance for the first half of the year, with a net profit attributable to the parent company of 36.9673 million yuan, a decrease of 28.00%
Dongbao Bio-Tech released its semi-annual report for 2025, with operating revenue of 369 million yuan, a year-on-year decrease of 16.93%; net profit attributable to the parent company was 36.9673 million yuan, a year-on-year decline of 28.00%; net profit excluding non-recurring gains and losses was 33.4351 million yuan, a year-on-year decrease of 27.41%; basic earnings per share were 0.0629 yuan
According to the Zhitong Finance APP, Dongbao Bio-Tech (300239.SZ) released its semi-annual report for 2025, showing an operating income of 369 million yuan, a year-on-year decrease of 16.93%. The net profit attributable to shareholders of the listed company was 36.9673 million yuan, a year-on-year decrease of 28.00%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 33.4351 million yuan, a year-on-year decrease of 27.41%. The basic earnings per share were 0.0629 yuan
